SkinbiotherapeuticsSBTX 
$0.13-0.94%24h
-0.94%24h
Global rank
Market cap$21.67M
Change 7d-14.95%
YTD Performance-30.98%
SP500 benchmarkUnderperform
P/E-7.65
P/S131.28
Revenue$165.04K
Earnings-$3.54M
Dividend yield-
Main Sector
Healthcare
Category
Skinbiotherapeutics (SBTX) Total Liabilities
SBTX Total Liabilities in 2022: $749.04K
According to Skinbiotherapeutics latest financial reports the total liabilities of SBTX is $749.04K, an decrease of -1.68% to 2022. At the end of 2022 company had $761.86K total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Skinbiotherapeutics is responsible for during its operational activities.
Skinbiotherapeutics (SBTX) Total Liabilities History from 2023 to 2022
-
Value:-
SBTX Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $749.04K | -1.68% |
| 2022 | $761.86K | 17.31% |
| 2021 | $649.47K | 70.48% |
| 2020 | $380.95K | 151.22% |
| 2019 | $151.64K | - |
View the Top Total Liabilies Stocks
